AMPH
AMPH
NASDAQ · Pharmaceuticals

Amphastar Pharmaceuticals In

$18.81
-0.60 (-3.09%)
Analyst Consensus
Sell
12
Analysts
Moderate
Coverage
Buy 0 0%
Hold 9 75%
Sell 3 25%
Price Target
Analyst Price Target +244.1% upside
Low Target $41.78
Average Target $64.73
High Target $94.19
Current Price $18.81
Current
$18.81
Target
$64.73
$41.78 $64.73 avg $94.19
Scenario Analysis
Bear Case
$41.78
122.1%
Low target
Base Case
$64.73
+244.1%
Avg target
Bull Case
$94.19
+400.7%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$31.26
-39.8% from high
52-Week Low
$16.65
+13.0% from low
Target vs 52W High
$64.73
+107.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%